You are here

APX3330

Ocuphire still focused on FDA approval despite diabetic eye drug missing phase 2 endpoint

Fierce Biotech

Thu, 01/26/23 - 10:39 am

Ocuphire Pharma

diabetic retinopathy

clinical trials